Skip to content
  • Sunday, 26 July 2026
  • 5:40 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Molecular Gateway to Relief How TRPV4 Functions as the Biological Off Switch for Scratching Behavior in Chronic Itch Disorders
Neuroscience & Brain Research

Molecular Gateway to Relief How TRPV4 Functions as the Biological Off Switch for Scratching Behavior in Chronic Itch Disorders

Rifan Muazin May 10, 2026 0

Scientists have identified a critical biological "off-switch" for scratching behavior, a discovery that could revolutionize the treatment of chronic itch…

Read More
Neuroscience & Brain Research

Astrocytes and the Neuroscience of Fear: How Star-Shaped Cells Regulate Memory and Anxiety Disorders

Rifan Muazin May 2, 2026 0

For decades, the prevailing narrative in neuroscience centered almost exclusively on the neuron as the primary architect of human thought,…

Read More
Stem Cell & Regenerative Medicine

Deciphering the Inflammatory Niche: How Bone Marrow Microenvironments Drive the Progression of Pre-Leukemic States and Age-Related Blood Disorders

Dwi Wanna Apr 24, 2026 0

Every second, the human bone marrow performs a biological feat of staggering proportions, generating millions of fresh blood and immune…

Read More
Laboratory Automation & Robotics

OrsoBio’s LXR Inverse Agonist Shows Promise for Hard-to-Treat Triglyceride Disorders, Paving New Path Beyond GLP-1 Dominance

Lana Keisha Apr 14, 2026 0

OrsoBio, a specialized biotechnology firm dedicated to pioneering therapies for obesity and its associated metabolic conditions, is strategically charting a…

Read More
Neuroscience & Brain Research

Early Life Stress Linked to Long-Term Gastrointestinal Disorders Through Brain-Gut Communication Pathways

Rifan Muazin Apr 4, 2026 0

A comprehensive multi-institutional study published in the journal Gastroenterology has established a profound link between early life adversity and the…

Read More
Laboratory Automation & Robotics

OrsoBio’s LXR inverse agonist shows promise for hard-to-treat triglyceride disorders

Lana Keisha Apr 3, 2026 0

OrsoBio, a specialized biotechnology company strategically focused on addressing obesity and its myriad related metabolic dysfunctions, is charting a course…

Read More
Neuroscience & Brain Research

Microplastic Ingestion and Inhalation Linked to the Acceleration of Neurodegenerative Disorders Through Multiple Biological Pathways

Rifan Muazin Mar 29, 2026 0

The pervasive presence of microplastics in the global environment has long been a concern for marine biologists and ecologists, but…

Read More
Laboratory Automation & Robotics

OrsoBio’s LXR inverse agonist shows promise for hard-to-treat triglyceride disorders

Lana Keisha Mar 26, 2026 0

OrsoBio, a specialized biotechnology firm dedicated to pioneering treatments for obesity and its associated metabolic disorders, is strategically charting a…

Read More
Neuroscience & Brain Research

Early Life Stress and the Gut-Brain Axis: New Research Identifies Critical Links Between Childhood Adversity and Chronic Digestive Disorders

Rifan Muazin Mar 26, 2026 0

The intricate connection between the human mind and the digestive system has long been a subject of medical inquiry, but…

Read More
Laboratory Automation & Robotics

OrsoBio’s LXR inverse agonist shows promise for hard-to-treat triglyceride disorders and pioneering a new frontier in obesity therapeutics

Lana Keisha Mar 19, 2026 0

OrsoBio, a dynamic biotech enterprise dedicated to advancing novel therapies for obesity and a spectrum of obesity-related metabolic disorders, is…

Read More

Posts pagination

1 2 3
Beyond Neurons: How Astrocytes Shape the Architecture of Fear and Memory in the BrainA Surprising Discovery on a Baltic Island Rewrites the Ancient Human-Wolf RelationshipTWiV 1288: Clinical Update with Dr. Daniel Griffin Examines Alarming Shifts in Childhood Immunization Schedules Amidst Resurging Public Health ThreatsKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ